The Charity’s UK advocacy began in 2016 with events held at Oxford Town Hall, as part of the charity’s promotion and fundraising activities. Since 2020, the Charity has provided support for the annual the London Global Cancer Week (LGCW) conference, which yearly has attracted increasingly larger attendance and substantial external funding.

The purpose of LGCW is to promote activities for improving healthcare for cancer patients in developing countries both in the UK and in LMICs. The nature of the event is a series of meetings, webinars, discussion and workshops within a fixed timeframe (one week). The main PIs for LGCW are Mr Mark Lodge and Dr Susannah Stanway.

The London Global Cancer Week conference ran from 13-18 November 2023 and featured 32 events presenting 201 expert speakers and drawing an estimated audience of 2500+ attendees from 150 countries. Topics ranged from policy making to data collection in African hospitals and providing cancer care and conducting cancer research in times of conflict. Events included sessions hosted by WHO (in association with IARC and IAEA), NCI Kyiv and a Parliamentary event at the Houses of Parliament hosted jointly by the Lancet Oncology.

The test for each LGCW is how successfully it has shared knowledge and provided the opportunity for new developments and positive change. LGCW 2023 provided a platform for a presentation on Cancer Surveillance in sub Saharan Africa featuring the work of the African Cancer Registry Network, a key project supported by the Charity. (This session is viewable at https://www.lgcw.org.uk/watch-again/) The conference included an influential Round Table discussion on Building Health Care Systems Resilience in Low and Middle Income Countries; a summary of which is published in Cancer Control 2024 (ref: https://www.cancercontrol.info/wp-content/uploads/2024/10/24-27-roundtable.pdf). LGCW 2023 was also marked by the historic broadcast by the Commonwealth Secretary General Rt Hon. Patricia Scotland K.C. committing the Commonwealth to aligning itself with the conference in the pursuit of the elimination of cervical cancer within its member states.